Human challenge trials offer a complementary approach. By safely and deliberately exposing healthy adult volunteers to a well characterised virus under controlled conditions, researchers can generate ...

Respiratory syncytial virus (RSV) is spreading across the country, but it’s not too late to take steps to protect babies from ...

New FDA-approved immunizations are crucial for protecting infants from RSV, a leading cause of hospitalization for babies ...

The Family Health Care Institute (one of the King Hussein Foundation institutes) provides the reader today, Wednesday, with ...

The European approval for GSK's depemokimab joins recently announced data on vaccine efficacy and progress on 4-month viral treatments.

Clinicians underutilize RSV testing in adults with respiratory or cardiac exacerbations, potentially obscuring the true burden of disease.

Among children younger than 2, the preventive effects of nirsevimab against RSV were maintained for up to 12 months after administration.

From early failures to prefusion F protein breakthroughs, RSV vaccine development has accelerated, reshaping prevention strategies for infants and older adults.

The vaccine became available in 2023 and has quickly gained usage in the Mountain West.

A Dublin mother's 7-week-old daughter went from congested to fighting for her life in less than 48 hours after being diagnosed with RSV.

RSV is a rapidly spreading virus that infects the lungs and respiratory tract. It spreads through coughs, sneezes, or close ...

A GP has revealed key differences between Covid, flu and cold symptoms to help you identify which illness you may have ...